Email Newsletters

Life Sciences

Phio Pharmaceuticals to partner with Dutch firm on cancer treatments

Marlborough startup biotech Phio Pharmaceuticals will collaborate with a Dutch company to develop immunotherapies for cancer treatment.

Three MetroWest businesses win tax break approval

Medical device company Candela, life sciences manufacturer Lykan Bioscience and medical optics firm Olympus Corporation of the Americas have been approved for new tax breaks.

Southborough science software firm Arxspan acquired by $6B firm

Southborough cloud-based scientific software firm Arxspan has been acquired by the publicly traded scientific equipment firm Bruker Corp., based in Billerica.

Hologic wins U.S., Canada & European approval for OG-BYN scope

Marlborough medical device maker Hologic has been granted approval from three geographic markets since December for a three-in-one hysteroscope.
ADVERTISEMENT

Southbridge Tech Incubator seeks startups

The Southbridge Tech Incubator, the first Central Mass. South technical co-working space, is now accepting lease applications.

Syneron-Candela rebrands as ahead of Marlborough HQ move

As it prepares its headquarters move to Marlborough, Wayland medical device company Syneron-Candela has rebranded to only Candela.

Harvard Bioscience profits jump 76%

Revenue at Holliston medical device maker Harvard Bioscience climbed 20 percent last year, with profits rising to $7.4 million, the company said Thursday.

Insulet records first profitable year with 22% revenue growth

Acton insulin pump manufacturer Insulet has reached profitability for the first year in the company's history, reporting $3.3 million in net income as revenues increased 22 percent in 2018.
ADVERTISEMENT

LakePharma launches gene therapy facility at Gateway Park

California biologics company LakePharma has launched a viral vector facility in its Gateway Park operations on Worcester Polytechnic Institute's campus.

New CEO at Phio Pharmaceuticals ramping up R&D

Marlborough startup drugmaker Phio Pharmaceuticals has changed its name, CEO and model as it attempts to become a cancer therapeutics firm.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA